Health Check: The urge to merge is spurring a global biotech recovery
A burst of global M&A activity suggests biotech sector is regaining its mojo Dimerix is well cashed up as pivotal trial recruitment hits halfway mark Pacific Edge wins a two-month reprieve from US reimbursement authorities Industry watchers expect …